BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
torrent pharmaceuticals l stock

TORRENT PHARMACEUTICALS L Share Price

3339.9 12.04 (0.36%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: TORNTPHARM

TORRENT PHARMACEUTICALS L Share Price Update

As of the latest trading session, TORRENT PHARMACEUTICALS L share price is currently at 3339.9, which is up by 12.04 from its previous closing. Today, the stock has fluctuated between 3294.05 and 3354.90. Over the past year, TORRENT PHARMACEUTICALS L has achieved a return of 60.92 %. In the last month alone, the return has been 7.35 %. Read More...

TORRENT PHARMACEUTICALS L Performance

Day Range

Low3294.05 High3354.90
3345.85

52 Week Range

Low 2025.70 High 3590.70
3345.85

TORRENT PHARMACEUTICALS L Share Price

3518

500420

TORNTPHARM

img img img img
No Data Available

Open Price

3321.00

Prev. Close

3327.85

Volume (Shares)

244920.00

Total traded value

8194.65

Upper Circuit

3660.60

Lower Circuit

2995.10

Note: The current prices & values are delayed, Login to your account for live updates.

TORRENT PHARMACEUTICALS L Fundamentals


(Standalone)

Market Cap (Cr) 113037.40
PE Ratio (TTM) 69.25
Book Value / Share 222.38
Beta 0.40
ROE 20.43%
EPS (TTM) 48.34
Dividend Yield 0.84%
Net Profit Qtr (Cr) 460.00

TORRENT PHARMACEUTICALS L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 2376.00
Operating Expense 1757.00
Net Profit 460.00
Net Profit Margin (%) 19.36
Earnings Per Share (EPS) 13.60
EBITDA 914.00
Effective Tax Rate (%) 31.34
Particulars JUN 2024 (Values in Cr)
Revenue 2394.00
Operating Expense 1792.00
Net Profit 469.00
Net Profit Margin (%) 19.59
Earnings Per Share (EPS) 13.86
EBITDA 920.00
Effective Tax Rate (%) 29.68
Particulars MAR 2024 (Values in Cr)
Revenue 2094.00
Operating Expense 1689.00
Net Profit 410.00
Net Profit Margin (%) 19.57
Earnings Per Share (EPS) 12.12
EBITDA 792.00
Effective Tax Rate (%) 22.64
Particulars DEC 2023 (Values in Cr)
Revenue 2083.00
Operating Expense 1682.00
Net Profit 297.00
Net Profit Margin (%) 14.25
Earnings Per Share (EPS) 8.78
EBITDA 690.00
Effective Tax Rate (%) 30.93
Particulars SEP 2023 (Values in Cr)
Revenue 2115.00
Operating Expense 1679.00
Net Profit 327.00
Net Profit Margin (%) 15.46
Earnings Per Share (EPS) 9.65
EBITDA 751.00
Effective Tax Rate (%) 32.15
Particulars MAR 2024 (Values in Cr)
Revenue 8370.00
Operating Expense 6707.00
Net Profit 1357.00
Net Profit Margin (%) 16.21
Earnings Per Share (EPS) 40.10
EBITDA 2981.00
Effective Tax Rate (%) 29.21
Particulars MAR 2023 (Values in Cr)
Revenue 7547.00
Operating Expense 6200.00
Net Profit 1052.00
Net Profit Margin (%) 13.93
Earnings Per Share (EPS) 31.07
EBITDA 2547.00
Effective Tax Rate (%) 33.29
Particulars MAR 2022 (Values in Cr)
Revenue 6666.00
Operating Expense 5480.00
Net Profit 991.00
Net Profit Margin (%) 14.86
Earnings Per Share (EPS) 58.59
EBITDA 2304.00
Effective Tax Rate (%) 32.40
Particulars MAR 2021 (Values in Cr)
Revenue 6333.00
Operating Expense 5203.00
Net Profit 1138.00
Net Profit Margin (%) 17.96
Earnings Per Share (EPS) 67.24
EBITDA 2315.00
Effective Tax Rate (%) 16.69
Particulars MAR 2020 (Values in Cr)
Revenue 6026.00
Operating Expense 5288.00
Net Profit 939.00
Net Profit Margin (%) 15.58
Earnings Per Share (EPS) 55.46
EBITDA 2154.00
Effective Tax Rate (%) 15.93
Particulars MAR 2024 (Values in Cr)
Book Value / Share 202.57
ROE % 25.38
ROCE % 23.21
Total Debt to Total Equity 0.72
EBITDA Margin 32.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 183.13
ROE % 20.50
ROCE % 19.48
Total Debt to Total Equity 0.78
EBITDA Margin 30.01
Particulars MAR 2022 (Values in Cr)
Book Value / Share 351.75
ROE % 18.26
ROCE % 18.20
Total Debt to Total Equity 0.76
EBITDA Margin 30.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 344.90
ROE % 23.49
ROCE % 16.96
Total Debt to Total Equity 1.00
EBITDA Margin 31.69
Particulars MAR 2020 (Values in Cr)
Book Value / Share 284.99
ROE % 21.47
ROCE % 14.79
Total Debt to Total Equity 1.24
EBITDA Margin 28.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 201.76
ROE % 20.43
ROCE % 20.40
Total Debt to Total Equity 0.60
EBITDA Margin 34.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 190.75
ROE % 16.43
ROCE % 17.68
Total Debt to Total Equity 0.62
EBITDA Margin 33.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share 374.94
ROE % 16.02
ROCE % 16.57
Total Debt to Total Equity 0.63
EBITDA Margin 34.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 356.30
ROE % 20.41
ROCE % 15.96
Total Debt to Total Equity 0.87
EBITDA Margin 35.81
Particulars MAR 2020 (Values in Cr)
Book Value / Share 302.59
ROE % 18.52
ROCE % 14.41
Total Debt to Total Equity 1.08
EBITDA Margin 34.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 839.04
Total Assets 15060.58
Total Liabilities 15060.58
Total Equity 6856.15
Share Outstanding 338445440
Price to Book Ratio 12.89
Return on Assets (%) 10.99
Return on Capital (%) 15.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 571.46
Total Assets 15011.85
Total Liabilities 15011.85
Total Equity 6198.07
Share Outstanding 338445440
Price to Book Ratio 8.06
Return on Assets (%) 8.29
Return on Capital (%) 10.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 403.41
Total Assets 13099.84
Total Liabilities 13099.84
Total Equity 5952.95
Share Outstanding 169222720
Price to Book Ratio 7.46
Return on Assets (%) 5.93
Return on Capital (%) 7.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 603.50
Total Assets 14074.65
Total Liabilities 14074.65
Total Equity 5837.17
Share Outstanding 169222720
Price to Book Ratio 7.13
Return on Assets (%) 8.89
Return on Capital (%) 11.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 666.65
Total Assets 14009.74
Total Liabilities 14009.74
Total Equity 4823.22
Share Outstanding 169222720
Price to Book Ratio 6.52
Return on Assets (%) 7.31
Return on Capital (%) 11.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 108.76
Total Assets 12376.59
Total Liabilities 12376.59
Total Equity 6828.76
Share Outstanding 338445440
Price to Book Ratio 12.89
Return on Assets (%) 10.96
Return on Capital (%) 13.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 147.61
Total Assets 12871.93
Total Liabilities 12871.93
Total Equity 6455.96
Share Outstanding 338445440
Price to Book Ratio 8.06
Return on Assets (%) 8.16
Return on Capital (%) 9.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 69.46
Total Assets 11152.56
Total Liabilities 11152.56
Total Equity 6345.42
Share Outstanding 169222720
Price to Book Ratio 7.46
Return on Assets (%) 8.88
Return on Capital (%) 10.23
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 66.42
Total Assets 11761.04
Total Liabilities 11761.04
Total Equity 6030.10
Share Outstanding 169222720
Price to Book Ratio 7.13
Return on Assets (%) 9.67
Return on Capital (%) 10.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 390.95
Total Assets 11884.47
Total Liabilities 11884.47
Total Equity 5120.97
Share Outstanding 169222720
Price to Book Ratio 6.52
Return on Assets (%) 7.89
Return on Capital (%) 10.39
Particulars MAR 2024 (Values in Cr)
Net Income 2352.11
Cash from Operations 3764.18
Cash from Investing -167.90
Cash from Financing -2779.64
Net change in Cash 318.54
Free Cash Flow 4196.96
Particulars MAR 2023 (Values in Cr)
Net Income 1847.16
Cash from Operations 2766.20
Cash from Investing -2415.31
Cash from Financing 77.36
Net change in Cash 30.18
Free Cash Flow 3340.14
Particulars MAR 2022 (Values in Cr)
Net Income 1225.91
Cash from Operations 2224.01
Cash from Investing -196.63
Cash from Financing -1781.05
Net change in Cash -174.69
Free Cash Flow 2426.58
Particulars MAR 2021 (Values in Cr)
Net Income 1526.26
Cash from Operations 2180.85
Cash from Investing -449.42
Cash from Financing -1650.79
Net change in Cash -94.86
Free Cash Flow 2516.00
Particulars MAR 2020 (Values in Cr)
Net Income 1186.57
Cash from Operations 1676.95
Cash from Investing 198.61
Cash from Financing -1549.04
Net change in Cash 42.48
Free Cash Flow 2083.73
Particulars MAR 2024 (Values in Cr)
Net Income 1916.57
Cash from Operations 3217.78
Cash from Investing -296.07
Cash from Financing -2577.57
Net change in Cash 19.46
Free Cash Flow 3562.12
Particulars MAR 2023 (Values in Cr)
Net Income 1577.02
Cash from Operations 2537.87
Cash from Investing -2384.07
Cash from Financing 80.74
Net change in Cash -37.92
Free Cash Flow 3108.77
Particulars MAR 2022 (Values in Cr)
Net Income 1466.21
Cash from Operations 2380.37
Cash from Investing -159.70
Cash from Financing -1977.27
Net change in Cash 3.13
Free Cash Flow 2488.54
Particulars MAR 2021 (Values in Cr)
Net Income 1366.11
Cash from Operations 1782.79
Cash from Investing -316.28
Cash from Financing -1581.20
Net change in Cash -324.59
Free Cash Flow 1984.78
Particulars MAR 2020 (Values in Cr)
Net Income 1116.77
Cash from Operations 1786.60
Cash from Investing 269.43
Cash from Financing -1555.48
Net change in Cash 293.85
Free Cash Flow 2132.79
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 3344.10
  • 26 Days 3273.20
  • 10 Days 3344.10
  • 50 Days 3296.90
  • 12 Days 3326.60
  • 100 Days 3275.10
  • 20 Days 3282.00
  • 200 Days 2685.60
3342.47
PIVOT
First Resistance 3380.03
Second Resistance 3432.22
Third Resistance 3469.78
First Support 3290.28
Second Support 3252.72
Third Support 3200.53
RSI 56.64
MACD 53.35
Commodity Channel Index (CCI) 51.69
ADX 17.58
Williams % R -38.08

Over 1 Month

down

7.35

Over 3 Months

down

-3.06

Over 6 Months

down

16.38

Over 1 Year

down

60.92

Over 3 Years

down

29.58

Over 5 Years

down

29.10

TORRENT PHARMACEUTICALS L Future

Future: Price

26 Dec
3349.20
30 Jan
3374.65
25 May
0 100 200 300 400 500 600

Discount/Premium

26 Dec
9.30
30 Jan
34.75
25 May
0 1 2 3 4 5 6 7

Active Calls

3400.0
675
3600.0
394
3350.0
340
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

3200.0
581
3300.0
243
3350.0
220
25 Jul
0 500 1000 1500 2000 2500

TORRENT PHARMACEUTICALS L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
7.21
Promoter Holdings
71.24
FII
14.46
DII
7.08
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Torrent Investments Private Limited Shareholding of Promoter and Promoter Group 2.4112744E8 71.25
Nps Trust Public Shareholding 4465862.0 1.32
Mehta Family Trust 4 Shareholding of Promoter and Promoter Group 0.0 0.0
Mehta Family Trust 3 Shareholding of Promoter and Promoter Group 0.0 0.0
Mehta Family Trust 2 Shareholding of Promoter and Promoter Group 0.0 0.0
Mehta Family Trust 1 Shareholding of Promoter and Promoter Group 0.0 0.0
Aman Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Shaan Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Varun Sudhir Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Jinal Sudhir Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Sapna Samir Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Anita Sudhir Mehta Shareholding of Promoter and Promoter Group 200.0 0.0
Samir Uttamlal Mehta Shareholding of Promoter and Promoter Group 400.0 0.0
Sudhir Uttamlal Mehta Shareholding of Promoter and Promoter Group 400.0 0.0

TORRENT PHARMACEUTICALS L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-12 22.0 Interim 2024-02-12 Equity shares 2023-06-23 8.0 Final 2023-06-23 Equity shares 2023-02-03 14.0 Interim 2023-02-03 Equity shares 2022-06-03 15.0 Special 2022-06-06 Equity shares 2022-06-03 8.0 Final 2022-06-06 Equity shares 2022-02-02 25.0 Interim 2022-02-03 Equity shares 2021-06-17 15.0 Final 2021-06-18 Equity shares 2021-02-15 20.0 Interim 2021-02-16 Equity shares 2020-03-18 17.0 Interim 2020-03-19 Equity shares 2020-03-18 15.0 Special 2020-03-19 Equity shares 2019-06-13 4.0 Final 2019-06-14 Equity shares 2019-02-06 13.0 Interim 2019-02-07 Equity shares 2018-06-18 5.0 Final 2018-06-20 Equity shares 2018-02-15 9.0 Interim 2018-02-19 Equity shares 2017-06-19 4.0 Final 2017-06-21 Equity shares 2017-02-10 10.0 Interim 2017-02-13 Equity shares 2016-03-16 15.0 Interim 2 2016-03-17 Equity shares 2016-02-11 20.0 Interim 2016-02-12 Equity shares 2015-06-15 6.25 Final 2015-06-17 Equity shares 2015-02-02 5.0 Interim 2015-02-03 Equity shares 2014-06-16 5.0 Final 2014-06-18 Equity shares 2014-01-24 5.0 Interim 2014-01-27 Equity shares 2013-06-10 7.0 Final 2013-06-12 Equity shares 2013-06-10 10.0 Special 2013-06-12 Equity shares 2013-02-01 6.0 Interim 2013-02-04 Equity shares 2012-06-11 2.5 Final 2012-06-13 Equity shares 2012-01-27 6.0 Interim 2012-01-30 Equity shares 2011-06-06 2.0 Special 2011-06-08 Equity shares 2011-06-06 6.0 Final 2011-06-08 Equity shares 2010-06-04 6.0 Final 2010-06-08 Equity shares 2009-06-08 4.0 Final 2009-06-10 Equity shares 2008-06-19 3.5 Final 2008-06-23 Equity shares 2007-03-23 3.0 Interim 2007-03-26 Equity shares 2006-06-15 0.0 Final 0001-01-01 Equity shares 2005-06-09 0.0 Final 2005-06-13 Equity shares
Ex-Date Ex-Bonus Ratio
2022-07-11 2022-07-08 1:1 2013-07-24 2013-07-23 1:1 2006-02-27 2006-02-20 1:1
Ex-Date Old FV NEW FV Record Date
2006-02-20 10.0 5.0 2006-02-27

Learn More About Stocks

About TORRENT PHARMACEUTICALS L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by TORRENT PHARMACEUTICALS L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Torrent Pharmaceuticals Ltd?

Answer Field

The share price of Torrent Pharmaceuticals Ltd for NSE is ₹ 3339.9 and for BSE is ₹ 3337.75.

What is the Market Cap of Torrent Pharmaceuticals Ltd?

Answer Field

The market cap of Torrent Pharmaceuticals Ltd for NSE is ₹ 11,30,37.40 Cr. and for BSE is ₹ 11,29,64.60 Cr. as of now.

What is the 52 Week High and Low of Torrent Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Torrent Pharmaceuticals Ltd for NSE is ₹ 3590.70 and ₹ 2073.45 and for BSE is ₹ 3589.95 and ₹ 2075.00.

How to Buy Torrent Pharmaceuticals Ltd share?

Answer Field

You can trade in Torrent Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Torrent Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 60.92%.

What is the Current Share Price of Torrent Pharmaceuticals Ltd?

Answer Field

Torrent Pharmaceuticals Ltd share price is for NSE ₹ 3339.9 & for BSE ₹ 3337.75 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Torrent Pharmaceuticals Ltd Share?

Answer Field

The market cap of Torrent Pharmaceuticals Ltd for NSE ₹ 11,30,37.40 & for BSE ₹ 11,29,64.60 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Torrent Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Torrent Pharmaceuticals Ltd share is 69.25.

What is the PB ratio of Torrent Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Torrent Pharmaceuticals Ltd share is 222.38.

How to Buy Torrent Pharmaceuticals Ltd Share?

Answer Field

You can trade in Torrent Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Torrent Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Torrent Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Torrent Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader